Date of Publication
1-21-2015
Abstract
Background:
Hepatitis C (HCV)
Viral infection of the liver spread primarily via blood-to-blood contact (e.g., intravenous drug use (IVDU))
United States: 3.2 million chronic HCV infections (2010)
Vermont: 1.63 cases per 1000 people (2012-2013)
Barriers to Care
Exclusion of current IV drug users from HCV treatment programs despite their high rates of infection
Lack of support, causing decreased treatment adherence
Poor access to treatment: cost, transportation, competing priorities of housing, addiction management, and food
HIV and HCV
Research has shown that the multidisciplinary and integrated HIV model is appropriate for HCV
Vermont CARES
Non-profit organization that provides comprehensive services to clients with HIV in Vermont
Advisor(s)
Jerry Larrabee, MD, University of Vermont College of Medicine
Peter Jacobsen, Vermont CARES
Agency
Vermont CARES
Subjects
Access to Health Services, HIV, Immunization and Infectious Diseases, Public Health Infrastructure
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 3.0 License
Recommended Citation
Brown, Alexandra; Genziano, Justin; Powers, Julia; Ramadan, Samy; Schumer, Amy; Shear, Matthew; Wang, Katherine; Jacobsen, Peter; and Larrabee, Jerry, "Living with Hepatitis C: A Vermont Needs Assessment" (2015). Public Health Projects, 2008-present. 220.
https://scholarworks.uvm.edu/comphp_gallery/220
Notes
Presented at the 2016 APHA Annual Meeting & Expo, Denver, CO, November 2, 2015.